August 23, 2017 7:15 AM ET

Healthcare Equipment and Supplies

Company Overview of LED Medical Diagnostics Inc.

Company Overview

LED Medical Diagnostics Inc. develops and markets medical devices in the dental industry under the VELscope trade name in North America. Its products include Velscope Vx system, a device for the enhanced visualization of mucosal abnormalities, such as oral cancer and premalignant dysplasia; VELscope Vx imaging adapter for fluorescence and white-light clinical imaging; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, a single use plastic sheath to prevent patient cross contamination; and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company also provides diagnostic imaging products and software to dental and oral health specialists....

235–5589 Byrne Road

Burnaby, BC V5J 3J1

Canada

Founded in 2003

54 Employees

Key Executives for LED Medical Diagnostics Inc.

CEO & Director
Total Annual Compensation: $300.0K
Executive VP & Director
Total Annual Compensation: $250.0K
Compensation as of Fiscal Year 2016.

LED Medical Diagnostics Inc. Key Developments

LED Medical Diagnostics Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017

LED Medical Diagnostics Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2017. For the quarter, the company reported revenues of USD 3,704,499 against USD 3,661,490 a year ago. Operating loss was USD 259,935 against USD 1,011,490 a year ago. Net income before income taxes was USD 905,233 against net loss before income taxes of USD 1,082,831 a year ago. Net income and comprehensive income was USD 905,233 against net loss and comprehensive loss of USD 1,082,831 a year ago. Cash flow used in operations was USD 1,096,973 against USD 820,560 a year ago. Purchase of equipment was USD 12,000. For the six months, the company reported revenues of USD 5,802,915 against USD 5,814,740 a year ago. Operating loss was USD 1,022,324 against USD 3,006,204 a year ago. Net loss before income taxes was USD 182,728 against USD 3,134,658 a year ago. Net loss and comprehensive loss was USD 182,728 against USD 3,134,658 a year ago. Cash flow used in operations was USD 2,456,317 against USD 1,505,387 a year ago. Purchase of equipment was USD 74,284 against USD 117,670 a year ago.

LED Medical Diagnostics Inc., Annual General Meeting, Aug 22, 2017

LED Medical Diagnostics Inc., Annual General Meeting, Aug 22, 2017, at 11:00 Pacific Standard Time. Location: Farris, Vaughan, Wills & Murphy LLP, 25th Floor, 700 West Georgia Street Vancouver British Columbia Canada Agenda: To receive the audited financial statements of the Corporation for the financial year ended December 31, 2016 and the report of the auditors thereon; to appoint Grant Thornton LLP as auditors of the Corporation for the coming year and to authorize the Board of Directors to fix the auditors' remuneration; to elect the directors of the Corporation for the upcoming year; to approve the stock option plan of the Corporation; to transact such other business as may properly come before the Meeting.

LED Medical Diagnostics Inc. Announces Financial Results for the First Quarter Ended March 31, 2017

LED Medical Diagnostics Inc. announced financial results for the first quarter ended March 31, 2017. The company reported revenue of $2.098 million, which is a decrease of 2% from the three months ended March 31, 2016 and a 13% increase in revenues from the three months ended December 31, 2016. The net loss was $1.08 million for the three months ended March 31, 2017, as compared to a net loss of $2.05 million for the three months ended March 31, 2016. Cash flow used in operations was $1.39 million during the three months ended March 31, 2017 compared to $684,000 during the three months ended March 31, 2016.

Similar Private Companies By Industry

Company Name Region
A.R. Medicom, Inc. Americas
ABK Biomedical Inc. Americas
AceAge Inc. Americas
Adaptaide Inc. Americas
Adjuvant Therapeutics Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
Private Placement
January 20, 2017
--
Merger/Acquisition
January 20, 2017
Apteryx, Inc.
Private Placement
December 21, 2016
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LED Medical Diagnostics Inc., please visit www.velscope.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.